Bjerkholt Eric
SEC-identified person · CIK 1197350 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Cerus Corp CERS | Director | filed 2018 - 2026 |
| Metagenomi, Inc. MGX | Director | filed 2025 - 2026 |
| Mirum Pharmaceuticals, Inc. MIRM | Chief Financial Officer | filed 2023 - 2026 |
| Surrozen, Inc./DE [SRZN] | Director | filed 2023 - 2026 |
| Graybug Vision, INC. GRAY | Director | filed 2020 - 2024 |
| Chinook Therapeutics, INC. KDNY | Chief Financial Officer | filed 2020 - 2023 |
| Aimmune Therapeutics, Inc. AIMT | Chief Financial Officer | filed 2017 - 2020 |
| Corium International, Inc. CORI | Director | filed 2015 - 2018 |
| Viracta Therapeutics, Inc. VIRX | Sr. VP, Corp. Dev. & Finance | filed 2006 - 2016 |
| Stemcells INC STEM | Director | filed 2006 - 2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.